GO TO RESIDENCY SECTIONGO TO FELLOWSHIP SECTION
Annals of Surgical Oncology Cover

Dr. Kelly McMasters Named New Editor-in-Chief for Annals of Surgical Oncology

Read More...

icon

Transplant Team Reaches Milestones

Read More...

icon

Department Resident Appears on Wheel of Fortune

Read More...

icon

Chairman of Department Named President of Society of Surgical Chairs

Read More...

icon

Dr. Kelly McMasters Contributes to Major Report that Sets Out to Accelerate Cancer Care and Research

Read More...

From the Chairman

The University of Louisville, Department of Surgery, has a long and proud tradition of excellence. From its inception in 1837, when the University of Louisville served as the premier medical training ground for the western frontier of the United States, the Department. Surgery has been at the forefront of surgical education, patient care, and research.
continued...

Dr. McMasters

Grand Rounds Calendar

Grand Rounds Speaker

Nov 24, 2017: No Meeting — Thanksgiving Weekend

Go to Calendar
Owen Frederick McMasters

For information on Brown Cancer Center Owen's Wish Fund for Cancer Immunotherapy Research, click here.

Direct links to specialties:

• • • • • • • • • • • • • • • • • • • • • • • • • • •

Annals of Surgical Oncology Cover

Dr. Kelly McMasters Named New Editor-in-Chief for Annals of Surgical Oncology

The Society of Surgical Oncology announced Kelly M. McMasters, MD, PhD as the new Editor-in-Chief of Annals of Surgical Oncology (ASO) effective March 2018. Dr. McMasters becomes only the second Editor in the journal’s nearly 25-year history to assume the role. He will oversee the print and online editions of ASO and with Mark Roh, MD, Executive Editor, will lead a prestigious editor roster of expert leaders in surgical oncology, including more than 20 section editors and associate section editors from around the world, as well as U.S.-based associate and deputy editors. Dr. McMasters begins his position on March 23, 2018 in conjunction with the journal’s 25th anniversary and the retirement of Charles M. Balch, MD, who established the prominence of the publication in the field of surgical oncology. Dr. McMasters will report directly to the SSO Executive Council and will carry out editorial responsibilities from his office in Louisville, KY.

"Annals of Surgical Oncology has a rich heritage as the premier source of clinical and translational science related to cancer surgery and multidisciplinary care. It is an honor and a privilege to lead an outstanding editorial board into the future," said Dr. McMasters.

ASO is the worldwide journal of choice of surgical oncologists and is the official journal of the Society of Surgical Oncology and the American Society of Breast Surgeons. According to Thompson-Reuters, in the 2016 impact factor ranking among all surgical oncology scholarly periodicals, ASO has the most citations of all surgical journals in the world, the highest number of source items, and a current impact factor of 4.041. The journal promotes clinical and translational cancer research, with an emphasis on clinical trials. Leading subject areas of ASO include Gastrointestinal Oncology, Breast Oncology, Hepatobiliary Tumors, Colorectal Cancer, Thoracic Oncology, and Translational Research. ASO strives to enhance the quality of life and survival of the surgical patient with cancer and to improve the practice environment in which high-quality surgical oncology care is delivered. ASO also facilitates the career development of surgical trainees and their transition into academic and community-based practice and publishes timely articles about public policy and patient advocacy issues related to the surgical patient with cancer.



BACK TO TOP
Dr. Christopher Jones

Transplant Team Reaches Milestones

The Transplant Team at Jewish Hospital reached two milestones this month. It completed 5,000 organ transplants, including its 900th liver transplant. The Division of Transplantation is in the UofL Department of Surgery and is led by Dr. Christopher Jones.


BACK TO TOP
Reunion

Price Institute of Surgical Research Celebrates 60 Years, Holds Reunion

The Price Institute of Surgical Research held a reunion Sept. 7 - 9 in honor of its 60th Anniversary. More than 30 people attended, including former Price fellows from all over the world. Additionally, a former Fulbright scholar returned from Moldova. Attendees gave scientific presentations and talks about the benefits of having done research at the Price Institute.

Visit here to see photos from the event.


BACK TO TOP
Dr. Kelly McMasters

Chairman of Department Named President of Society of Surgical Chairs

Dr. Kelly McMasters has been named president of the Society of Surgical Chairs (SSC), an international organization comprised of chairs of departments of surgery and surgical specialty departments of medical schools, academic medical centers and teaching hospitals of the United States and Canada. The purpose of the SSC is to cultivate and enhance academic surgery. The SSC is a managed program of the American College of Surgeons.



BACK TO TOP

Dr. Kelly McMasters

Dr. Kelly McMasters Contributes to Major Report that Sets Out to Accelerate Cancer Care and Research

A fundamental shift in how cancer research is conducted and how cancer care is delivered in the United State is required in order to deliver on the US Cancer Moonshot initiative, according to a major new report published today in The Lancet Oncology journal.

The report sets out a detailed roadmap to deliver on the Blue Ribbon Panel recommendations, including a focus on prevention, a new model for drug discovery and development, a vast expansion of patient access to clinical trials, and an emphasis on targeted interventions to improve cancer care for underserved groups, specifically children, cancer survivors and minority groups. The report emphasizes the importance of addressing health disparities in all recommendations.

The Lancet Oncology Commission on Future Research Priorities in the USA is authored by more than 50 leading oncologists in the United States, including Dr. Kelly M. McMasters and other members of leading US cancer organizations, and sets out 13 key priority areas, each with measurable goals, to focus the $2 billion of funding released to the National Cancer Institute as part of the 21st Century Cures Act.

It highlights how technological advances, including understanding and mapping pre-cancer biology and the rapid adoption of big data, as well as new collaborations across industry, patient groups, academia, government and clinical practice will be critical to advancing research, and ultimately improving patient care.

"Among the thousands of technical details necessary for the success of an actual Moonshot, some fundamental principles remained the same; chief among them was the necessity of reaching the moon. The Commission brought together experts from across the spectrum of oncology research to help define the proper trajectory for the mission ahead," says McMasters, President, Society of Surgical Oncology and Ben A. Reid, Sr., MD Professor and Chairman, The Hiram C. Polk, Jr., MD Department of Surgery, University of Louisville School of Medicine.

The Commission was launched on Nov. 1 at an event on Capitol Hill, Washington, DC and will be presented on Nov. 3 at the United Nations Association of New York Humanitarian Awards, where former Vice President Joe Biden is being honored for his work on improving cancer outcomes as part of the US Cancer Moonshot Initiative.

For access to the report, please visit: www.thelancet.com/commissions/usa-oncology


BACK TO TOP